Clinical Guideline: Adult Obesity Care

Overview

• Title: Obesity in Adults: A Clinical Practice Guideline (CMAJ, Aug 4, 2020).
• Purpose: Update guidance for primary care on assessment, prevention and management of adult obesity.
• Key framing: Obesity is a complex, chronic, relapsing disease driven by biological, environmental, genetic and psychosocial factors.
• Emphasis: Patient-centered health outcomes and reducing weight bias and stigma, not weight alone.

Definitions And Pathophysiology

• Obesity definition: BMI > 30 kg/m2; classes: class 1 (30–34.9), class 2 (35–39.9), class 3 (≥40).
• Adiposity impact: Excess/ectopic fat produces adipocytokines and inflammatory mediators raising cardiometabolic and cancer risk.
• Appetite regulation: Integrated central networks (hypothalamus, mesolimbic reward, prefrontal executive control); gut, pancreas, adipose mediators influence eating.
• Complications: Type 2 diabetes, gallbladder disease, NAFLD, gout, multiple cancers, reduced lifespan by ~6–14 years.

Scope And Users

• Target users: Primary health care professionals; also policy-makers and people affected by obesity and families.
• Focus: Adults; recommendations adaptable to resources and patient preferences; clinical discretion advised.

Assessment Principles

• Recognize obesity as a chronic disease and seek patient permission before discussing weight.
• Use the 5As framework to initiate discussions and assess readiness.
• Routine measurements: height, weight, BMI for all adults; measure waist circumference for BMI 25–35 kg/m2.
• Additional assessment: comprehensive history to identify root causes (biologic, medications, social determinants, trauma, mental health, eating disorders), physical exam, tailored lab tests.
• Recommended labs: blood pressure (both arms), fasting glucose or HbA1c, lipid panel; ALT when indicated to screen for NAFLD.
• Consider Edmonton Obesity Staging System for severity and guiding treatment.

Management Approach (5-Step Patient Journey)

• Step 1: Recognition — treat obesity nonjudgmentally as a chronic disease.
• Step 2: Assessment — identify drivers, complications, barriers; measure anthropometry and cardiometabolic risk.
• Step 3: Treatment discussion — personalized plans addressing root causes; combine medical nutrition therapy, physical activity, psychological interventions, pharmacotherapy, surgery as needed.
• Step 4: Agree goals — focus on meaningful health, function and quality-of-life outcomes; set realistic, sustainable behavior targets.
• Step 5: Follow-up & advocacy — long-term support, reassessment, and system-level advocacy to improve access.

Core Treatments

• Medical Nutrition Therapy
  • Foundation of care; personalize to patient values, culture and preferences.
  • Delivered by registered dietitians when available.
  • Typical achievable weight loss from behavioral changes: ~3–5% body weight; can produce meaningful health benefits.
  • Recommend nondieting approaches to improve quality of life and psychological outcomes.
• Physical Activity
  • Aerobic: 30–60 minutes moderate-to-vigorous activity most days for small weight/fat loss, visceral and ectopic fat reduction, fitness and mobility.
  • Resistance training: promotes maintenance or modest increases in lean mass and mobility.
  • High-intensity interval training can increase fitness with less time.
  • Physical activity improves cardiometabolic risk factors and mood even without weight loss.
• Psychological and Behavioral Interventions
  • Multicomponent interventions (behavior modification, cognitive strategies, values-based) should be included to support adherence and intrinsic motivation.
  • Longitudinal follow-up and consistent messaging to build self-efficacy.
  • Emphasize health improvements over weight as success metric.

Adjunctive Therapies

• Pharmacotherapy
  • Indications: BMI ≥30 kg/m2 or BMI ≥27 kg/m2 with adiposity-related complications, as adjunct to lifestyle and psychological care.
  • Options in guideline: liraglutide 3.0 mg, naltrexone–bupropion, orlistat.
  • Use pharmacotherapy also for weight-loss maintenance and diabetes risk reduction (where evidence supports).
  • Avoid off-label or unsupported OTC medications.
  • Consider psychiatric medication weight effects; use metformin or psychological therapy to prevent antipsychotic-associated weight gain.
• Bariatric Surgery
  • Consider for BMI ≥40 kg/m2 or BMI ≥35 kg/m2 with ≥1 adiposity-related disease.
  • May be considered for BMI 30–35 kg/m2 with poorly controlled type 2 diabetes despite optimal management.
  • Choice of procedure individualized with multidisciplinary team; avoid adjustable gastric banding and routine single-anastomosis gastric bypass.
  • Preoperative: comprehensive medical/nutritional evaluation, correct deficiencies, screen/treat OSA, smoking cessation.
  • Postoperative: structured follow-up, annual primary care reviews, nutrition/vitamin monitoring, access to multidisciplinary supports.

Special Populations And Considerations

• Reproductive-Age Women
  • Discuss preconception, gestational (target 5–9 kg) and postpartum weight-management goals.
  • Offer behavior-change interventions (nutrition and physical activity) preconception, during pregnancy and postpartum.
  • Do not prescribe metformin for gestational weight gain; avoid weight-management drugs during pregnancy/breastfeeding.
  • Provide additional breastfeeding support.
• Indigenous Peoples
  • Recommendations emphasize engaging social realities, validating stress/systemic disadvantage, negotiating small attainable steps, addressing anti-Indigenous bias and building culturally congruent relationships and knowledge.

Primary Care Delivery And Systems

• Primary care clinicians should initiate patient-centered conversations, ask permission, and identify people with overweight/obesity.
• Use collaborative deliberation and motivational interviewing to tailor manageable action plans.
• Recommend multicomponent primary care programs and group programs modeled on Diabetes Prevention Program and Look AHEAD.
• Technology and wearables: web/mobile platforms and activity trackers can extend reach and support; include individualized feedback.
• Education: include obesity content in undergraduate, graduate and continuing programs to fill clinician skill gaps.

Implementation, Access And Policy Issues

• Current gaps: poor access to interdisciplinary obesity care, long bariatric surgery wait times, no provincial public coverage for anti-obesity medications, and limited services in territories.
• Implementation resources: Obesity Canada guideline website hosts full guideline, tools, quick reference, and updates; guideline maintained as a living document.
• Advocacy needed to recognize obesity as a chronic disease and to improve coverage, access and training.

Recommendations Summary Table

Decisions

• Guideline endorses patient-centered, evidence-based management across prevention, behavioral, pharmacologic and surgical options.
• Final recommendations achieved consensus and are graded by evidence level; full details and chapter-specific evidence available at the guideline website.

Action Items

• Primary care teams: adopt the 5-step patient journey and 5As framework in routine practice.
• Measure anthropometry routinely and assess root causes, comorbidities, and barriers.
• Integrate medical nutrition therapy, physical activity, psychological supports; consider pharmacotherapy or surgical referral when indicated.
• Advocate locally and nationally for improved access, reimbursement and clinician training in obesity care.